Company Filing History:
Years Active: 2001-2004
Title: Shankar Saha: Innovator in CGRP Antagonists
Introduction
Shankar Saha is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of peptide antagonists, particularly in relation to calcitonin gene-related peptide (CGRP). With a total of 2 patents, his work focuses on enhancing the efficacy of CGRP antagonists.
Latest Patents
Shankar Saha's latest patents include innovative methods for inhibiting CGRP binding. This invention relates to antagonists of CGRP, specifically focusing on amino terminal modifications to peptides that improve their ability to bind to a member of the CGRP-receptor superfamily. Another patent involves peptide antagonists of the CGRP-receptor superfamily and methods of use, further emphasizing the importance of amino terminal modifications in enhancing binding capabilities.
Career Highlights
Shankar Saha is affiliated with Creighton University, where he continues to advance research in his field. His work has implications for various therapeutic applications, particularly in the treatment of conditions related to CGRP.
Collaborations
Some of his notable coworkers include Derek David Smith and Peter W Abel, who contribute to the collaborative research environment at Creighton University.
Conclusion
Shankar Saha's innovative work in the development of CGRP antagonists showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic strategies in the treatment of related conditions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.